Floatz logo

(±)-1-P-TOLYL-3-AZABICYCLO(3.1.0)HEXANE

Chronic Peripheral Neuropathy Pain in Diabetics

XTL BiopharmaceuticalsSmall moleculePhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

3 Active assets in the Chronic Peripheral Neuropathy Pain in Diabetics cohort.

Asset / SponsorPhaseRating
Pregabalin
Syeda Khatoon e Jannat Welfare Foundation
Phase 4BB
Duloxetine
University of Rochester
Phase 4BB
(±)-TRAMADOL
Turku University Hospital
Phase 4BB
Capsaicin
Thammasat University
Phase 2/3B
Oxycodone
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Phase 3B

View all 20 →

Same molecule, other indications

(±)-1-P-TOLYL-3-AZABICYCLO(3.1.0)HEXANE is also rated in:

diabetic neuropathyDormant
CCC
Indicative ·
53 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →